학술논문

Drug-repositioning screens identify triamterene as a selective drug for the treatment of DNA mismatch repair deficient cells
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 June 2017, 23(11):2880-2890)
Subject
Language
English
ISSN
15573265
10780432